Get started
Author

Ben Allal

Observed names: ALLAL, Cuider, Allal, Ben, B C Allal, B. Allal, Ben C. Allal, C Allal, C. Allal, C.B. Allal, Cuider Allal, Cuider Ben Allal
Institutions: Centre National de la Recherche Scientifique, Inserm, Centre de Recherches en Cancérologie de Toulouse, Institut universitaire du cancer de Toulouse Oncopole, Institut Claudius Regaud, Université de Toulouse
Observed institutions: Centre National de la Recherche Scientifique, Université Toulouse III - Paul Sabatier, Inserm, Centre Hospitalier Universitaire de Toulouse, Centre de Recherches en Cancérologie de Toulouse, Institut universitaire du cancer de Toulouse Oncopole, Institut de Pharmacologie et de Biologie Structurale, Centre de Physiopathologie de Toulouse-Purpan, Institut Claudius Regaud, Hôpital Purpan, Université de Toulouse
ORCID: 0000-0002-4207-2219
Observed ORCID: 0000-0002-4207-2219
OpenAlex ID: A5043171058
RhoA Prenylation Is Required for Promotion of Cell Growth and Transformation and Cytoskeleton Organization but Not for Induction of Serum Response Element Transcription
2000 · Cuider Allal, Gilles Favre, et al. · Journal of Biological Chemistry · 112
PDF
In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFR
2005 · Diane Balin-Gauthier, Jean-Pierre Delord, et al. · Cancer Chemotherapy and Pharmacology · 100
Hospicells (ascites‐derived stromal cells) promote tumorigenicity and angiogenesis
2009 · Marlene Pasquet, Muriel Golzio, et al. · International Journal of Cancer · 88
PDF
RhoB prenylation is driven by the three carboxyl-terminal amino acids of the protein: Evidenced in vivo by an anti-farnesyl cysteine antibody
2000 · Rudi Baron, Emmanuelle Fourcade, et al. · Proceedings of the National Academy of Sciences · 80
Pilot Study of Neoadjuvant Treatment with Erlotinib in Nonmetastatic Head and Neck Squamous Cell Carcinoma
2007 · Fabienne Thomas, Philippe Rochaix, et al. · Clinical Cancer Research · 71
In vivo restoration of RhoB expression leads to ovarian tumor regression
2008 · B Couderc, A Pradines, et al. · Cancer Gene Therapy · 67
Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells
2004 · Julien Mazières, Vanessa Tillement, et al. · Experimental Cell Research · 63
Formation of the eIF4F Translation–Initiation Complex Determines Sensitivity to Anticancer Drugs Targeting the EGFR and HER2 Receptors
2011 · Pierre Zindy, Yann Bergé, et al. · Cancer Research · 62
Cetuximab potentiates oxaliplatin cytotoxic effect through a defect in NER and DNA replication initiation
2008 · D Balin-Gauthier, J-P Delord, et al. · British Journal of Cancer · 54
PDF
Selective inhibition of HER2 inhibits AKT signal transduction and prolongs disease-free survival in a micrometastasis model of ovarian carcinoma
2005 · J.P. Delord, C. Allal, et al. · Annals of Oncology · 53
Development and validation of an UHPLC-MS/MS method for simultaneous quantification of ibrutinib and its dihydrodiol-metabolite in human cerebrospinal fluid
2018 · D. Beauvais, J.-F. Goossens, et al. · Journal of Chromatography B · 36
Farnesylated RhoB Prevents Cell Cycle Arrest and Actin Cytoskeleton Disruption Caused by the Geranylgeranyltransferase I Inhibitor GGTI-298
2002 · Cuider Allal, Anne Pradines, et al. · Cell Cycle · 35
PDF
The Farnesyltransferase Inhibitor FTI-277 Suppresses the 24-kDa FGF2-Induced Radioresistance in HeLa Cells Expressing Wild-Type RAS
1999 · Elizabeth Cohen-Jonathan, Christine Toulas, et al. · Radiation Research · 33
Epidermal Growth Factor Stimulates 3-Hydroxy-3-Methylglutaryl-coenzyme A Reductase Expression via the ErbB-2 Pathway in Human Breast Adenocarcinoma Cells
1999 · Raghda Asslan, Anne Pradines, et al. · Biochemical and Biophysical Research Communications · 32
Improved oligonucleotide uptake and stability by a new drug carrier, the SupraMolecular BioVector (SMBV)
1997 · Myriam Berton, Sophie Sixou, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 29
PDF
Preclinical and Clinical Evidence that Deoxy-2-[18F]fluoro- D -glucose Positron Emission Tomography with Computed Tomography Is a Reliable Tool for the Detection of Early Molecular Responses to Erlotinib in Head and Neck Cancer
2010 · Sébastien Vergez, Jean-Pierre Delord, et al. · Clinical Cancer Research · 28
Population Pharmacokinetics of Ibrutinib and Its Dihydrodiol Metabolite in Patients with Lymphoid Malignancies
2020 · Fanny Gallais, Loïc Ysebaert, et al. · Clinical Pharmacokinetics · 26
Tipifarnib Plus Tamoxifen in Tamoxifen-Resistant Metastatic Breast Cancer: A Negative Phase II and Screening of Potential Therapeutic Markers by Proteomic Analysis
2010 · Florence Dalenc, Sophie F. Doisneau-Sixou, et al. · Clinical Cancer Research · 25
Cetuximab pharmacokinetic/pharmacodynamics relationships in advanced head and neck carcinoma patients
2019 · Félicien Le Louedec, Catherine Alix‐Panabières, et al. · British Journal of Clinical Pharmacology · 24
An UPLC–MS/MS method for separation and accurate quantification of tamoxifen and its metabolites isomers
2014 · Cécile Arellano, Ben Allal, et al. · Journal of Pharmaceutical and Biomedical Analysis · 24
Serum protein signature may improve detection of ductal carcinoma in situ of the breast
2009 · J Solassol, P Rouanet, et al. · Oncogene · 24
Simultaneous monitoring of pazopanib and its metabolites by UPLC–MS/MS
2018 · Marie-Noëlle Paludetto, Florent Puisset, et al. · Journal of Pharmaceutical and Biomedical Analysis · 19
A fast UPLC–HILIC method for an accurate quantification of dendrogenin A in human tissues
2019 · Régis Soulès, Fabien Audouard-Combe, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 13
Trastuzumab induced in vivo tissue remodelling associated in vitro with inhibition of the active forms of AKT and PTEN and RhoB induction in an ovarian carcinoma model
2010 · J-P Delord, S Quideau, et al. · British Journal of Cancer · 13
PDF
SupraMolecular BioVectors (SMBV) improve antisense inhibition of erbB-2 expression
1998 · C Allal, S Sixou, et al. · British Journal of Cancer · 11
PDF
Works count: 62
Citation count: 1,149
H-index: 21
I10-index: 25
Year
Topic
Type